Aktuelle Finanznachrichten und Börseninfos direkt von der Quelle

Synergy Pharmaceuticals

ISIN: US8716393082
Land: .

Alle Mitteilungen

	21.05.13 16:01 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Presents Plecanatide Results From a La[...]
	21.05.13 16:00 NASDAQ OMX-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Presents Plecanatide Results From a La[...]
	14.05.13 14:54 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index
	14.05.13 14:53 NASDAQ OMX-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index
	09.05.13 23:34 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Reports First Quarter 2013 Financial R[...]
	16.04.13 18:07 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Announces Closing of Public Offering o[...]
	11.04.13 02:56 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Inc. Announces Pricing of Public Offer[...]
	09.04.13 22:37 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Inc. Announces Public Offering of Comm[...]
	18.03.13 22:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Reports 2012 Fourth Quarter and Full-Y[...]
	15.03.13 10:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals to Present Study Results From Plecanat[...]
	11.02.13 11:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals to Begin Trading on The NASDAQ Global [...]
	28.01.13 11:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Initiates Multiple Ascending Dose Phas[...]
	17.01.13 22:05 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Announces Closing of Merger With Calli[...]
	15.01.13 11:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Announces Approval of Merger With Call[...]
	02.01.13 11:00 DGAP-News: Synergy Pharmaceuticals Synergy Announces Positive Results From Plecanatide Phase IIb/[...]
	28.12.12 11:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Completes Phase I Trial of SP-333, a S[...]
	27.12.12 11:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Begins Phase IIb Trial of Plecanatide [...]
	14.12.12 14:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Presents Poster on Novel Mechanism of [...]
	22.10.12 23:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals to Present Poster on SP-333, an Agonis[...]
	22.10.12 23:00 DGAP-News: Synergy Pharmaceuticals Synergy Pharmaceuticals Highlights Mechanistic Features of Ple[...]

weitere Mitteilungen

News Service

Unternehmen

Alle Realtime Mitteilungen

weitere Mitteilungen

Kurschart

Kursdetails anzeigen

DGAP-Watchlist

zur Registrierung

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

Details zur Sanha-Anleihe

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Zur Studie